Concourse Financial Group Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,104
| Closed | -$29.9K | – | 463 |
|
|
2024
Q4 | $29.9K | Buy |
1,104
+34
| +3% | +$922 | ﹤0.01% | 1405 |
|
|
2024
Q3 | $27.4K | Hold |
1,070
| – | – | ﹤0.01% | 1428 |
|
|
2024
Q2 | $25.1K | Buy |
1,070
+43
| +4% | +$1.01K | ﹤0.01% | 1445 |
|
|
2024
Q1 | $29.5K | Sell |
1,027
-123
| -11% | -$3.54K | ﹤0.01% | 1390 |
|
|
2023
Q4 | $37.7K | Buy |
1,150
+193
| +20% | +$6.33K | ﹤0.01% | 1239 |
|
|
2023
Q3 | $26.7K | Sell |
957
-90
| -9% | -$2.51K | ﹤0.01% | 1344 |
|
|
2023
Q2 | $35.7K | Buy |
1,047
+16
| +2% | +$545 | ﹤0.01% | 1211 |
|
|
2023
Q1 | $31K | Buy |
1,031
+24
| +2% | +$722 | ﹤0.01% | 1289 |
|
|
2022
Q4 | $28.4K | Buy |
+1,007
| New | +$28.4K | ﹤0.01% | 1330 |
|
|
2022
Q3 | – | Sell |
-1,023
| Closed | -$32K | – | 2345 |
|
|
2022
Q2 | $32K | Sell |
1,023
-419
| -29% | -$13.1K | ﹤0.01% | 1256 |
|
|
2022
Q1 | $66K | Sell |
1,442
-19,846
| -93% | -$908K | ﹤0.01% | 1027 |
|
|
2021
Q4 | $1.3M | Buy |
21,288
+5,657
| +36% | +$347K | 0.07% | 265 |
|
|
2021
Q3 | $1.17M | Buy |
15,631
+7,466
| +91% | +$558K | 0.07% | 277 |
|
|
2021
Q2 | $755K | Buy |
8,165
+1,942
| +31% | +$180K | 0.05% | 366 |
|
|
2021
Q1 | $552K | Buy |
6,223
+2,398
| +63% | +$213K | 0.04% | 407 |
|
|
2020
Q4 | $357K | Buy |
3,825
+3,343
| +694% | +$312K | 0.03% | 453 |
|
|
2020
Q3 | $31K | Buy |
+482
| New | +$31K | ﹤0.01% | 1213 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2268 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 2346 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2264 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1962 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 2397 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 2417 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2281 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1814 |
|